Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Jim Johnson

ID: 1b8379ff-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA and EMA Address Quality and Manufacturing Challenges for Breakthrough Therapies Undergoing Expedited Approval

Focus on Regulation · August 5, 2019

New FDA draft guidance on voluntary recalls highlights importance of recall initiation plans

Focus on Regulation · April 25, 2019

FDA Finalizes Data Integrity Guidance, With Some Noteworthy Changes

Focus on Regulation · December 12, 2018

China Takes Significant Steps to Consolidate Generic Drug Industry and Lower Prices

Focus on Regulation · December 10, 2018

FDA introduces new standardized inspection protocols for sterile drug manufacturers to modernize and strengthen oversight

Focus on Regulation · November 15, 2018

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog